These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7787940)

  • 21. [Pharmacogenetics in pediatrics].
    Aigrain EJ
    Arch Pediatr; 2000 May; 7 Suppl 2():365s-367s. PubMed ID: 10904775
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical pharmacokinetics in infants and children. A reappraisal.
    Kearns GL; Reed MD
    Clin Pharmacokinet; 1989; 17 Suppl 1():29-67. PubMed ID: 2692939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacogenetics: relevant aspects for the practicing veterinarian].
    Jud Schefer R; Paine Kuhn C; Demuth D
    Schweiz Arch Tierheilkd; 2012 Dec; 154(12):521-7. PubMed ID: 23188764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma paroxonase activity in old age.
    Playfer JR; Powell C; Evans DA
    Age Ageing; 1977 May; 6(2):89-95. PubMed ID: 888750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric pharmacology in the first year of life.
    Sumpter A; Anderson BJ
    Curr Opin Anaesthesiol; 2009 Aug; 22(4):469-75. PubMed ID: 19593898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical aspects of drug interactions. Mechanisms of interactions].
    Prandota J; Witkowska M
    Postepy Hig Med Dosw; 1976; 30(4):493-514. PubMed ID: 1005259
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacogenetics: multiple interactions between genes and environment as determinants of drug response.
    Vesell ES
    Am J Med; 1979 Feb; 66(2):183-7. PubMed ID: 425962
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical pharmacology.
    Reidenberg MM
    JAMA; 1991 Jun; 265(23):3107-9. PubMed ID: 2041114
    [No Abstract]   [Full Text] [Related]  

  • 29. Ontogeny of Pediatric Pharmacogenetics: Celebrating the Past and Vision for the Future.
    Leeder JS
    J Pediatr Pharmacol Ther; 2022; 27(1):4-11. PubMed ID: 35002553
    [No Abstract]   [Full Text] [Related]  

  • 30. LPS-Induced Inflammation Affects Midazolam Clearance in Juvenile Mice in an Age-Dependent Manner.
    Zheng Y; Ye PP; Zhou Y; Wu SY; Liu XT; Du B; Tang BH; Kan M; Nie AQ; Yin R; Wang M; Hao GX; Song LL; Yang XM; Huang X; Su LQ; Wang WQ; van den Anker J; Zhao W
    J Inflamm Res; 2021; 14():3697-3706. PubMed ID: 34377007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Biopredictive In Vitro Approach for Assessing Compatibility of a Novel Pediatric Hydrocortisone Drug Product within Common Pediatric Dosing Vehicles.
    Wollmer E; Karkossa F; Freerks L; Hetberg AE; Neal G; Porter J; Whitaker MJ; Margetson D; Klein S
    Pharm Res; 2020 Sep; 37(10):203. PubMed ID: 32968894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigallocatechin-3-Gallate Toxicity in Children: A Potential and Current Toxicological Event in the Differential Diagnosis With Virus-Triggered Fulminant Hepatic Failure.
    Sergi CM
    Front Pharmacol; 2019; 10():1563. PubMed ID: 32063842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety Extrapolation Analyses for Atomoxetine in Young Children with Attention-Deficit/Hyperactivity Disorder.
    Upadhyaya H; Kratochvil C; Ghuman J; Camporeale A; Lipsius S; D'Souza D; Tanaka Y
    J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):799-809. PubMed ID: 25265343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atomoxetine: a novel treatment for child and adult ADHD.
    Ledbetter M
    Neuropsychiatr Dis Treat; 2006 Dec; 2(4):455-66. PubMed ID: 19412494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Future pharmacologic agents for treatment of heart failure in children.
    Moffett BS; Chang AC
    Pediatr Cardiol; 2006; 27(5):533-51. PubMed ID: 16933064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age.
    Ganiere-Monteil C; Medard Y; Lejus C; Bruneau B; Pineau A; Fenneteau O; Bourin M; Jacqz-Aigrain E
    Eur J Clin Pharmacol; 2004 Apr; 60(2):89-96. PubMed ID: 15022030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastroesophageal reflux in children: pathogenesis, prevalence, diagnosis, and role of proton pump inhibitors in treatment.
    Gold BD; Freston JW
    Paediatr Drugs; 2002; 4(10):673-85. PubMed ID: 12269842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytochrome P450 3A: ontogeny and drug disposition.
    de Wildt SN; Kearns GL; Leeder JS; van den Anker JN
    Clin Pharmacokinet; 1999 Dec; 37(6):485-505. PubMed ID: 10628899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dextromethorphan in nonketotic hyperglycinaemia: metabolic variation confounds the dose-response relationship.
    Arnold GL; Griebel ML; Valentine JL; Koroma DM; Kearns GL
    J Inherit Metab Dis; 1997 Mar; 20(1):28-38. PubMed ID: 9061564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics and development: are infants and children at increased risk for adverse outcomes?
    Kearns GL
    Curr Opin Pediatr; 1995 Apr; 7(2):220-33. PubMed ID: 7787940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.